IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID (2013)
- Authors:
- USP affiliated authors: KALLAS, ESPER GEORGES - FM ; KALIL FILHO, JORGE ELIAS - FM
- Unidade: FM
- DOI: 10.1371/journal.pone.0075199
- Subjects: DOENÇAS AUTOIMUNES; TÉCNICAS E PROCEDIMENTOS DE LABORATÓRIO; CITOMETRIA DE FLUXO; IMUNOLOGIA CELULAR
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2013
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
PAQUIN-PROULX, Dominic et al. IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID. PLOS ONE, v. 8, n. 10, p. 9 , 2013Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0075199. Acesso em: 29 dez. 2025. -
APA
Paquin-Proulx, D., Santos, B. A. N., Carvalho, K. I., Toledo-Barros, M., Oliveira, A. K. B. de, Kokron, C. M., et al. (2013). IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID. PLOS ONE, 8( 10), 9 . doi:10.1371/journal.pone.0075199 -
NLM
Paquin-Proulx D, Santos BAN, Carvalho KI, Toledo-Barros M, Oliveira AKB de, Kokron CM, Kalil J, Moll M, Kallas EG, Sandberg JK. IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID [Internet]. PLOS ONE. 2013 ; 8( 10): 9 .[citado 2025 dez. 29 ] Available from: https://doi.org/10.1371/journal.pone.0075199 -
Vancouver
Paquin-Proulx D, Santos BAN, Carvalho KI, Toledo-Barros M, Oliveira AKB de, Kokron CM, Kalil J, Moll M, Kallas EG, Sandberg JK. IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID [Internet]. PLOS ONE. 2013 ; 8( 10): 9 .[citado 2025 dez. 29 ] Available from: https://doi.org/10.1371/journal.pone.0075199 - CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children
- Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine
- Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection
- Invariant natural killer T cells in patients with common variable immunodeficiency [Carta]
- A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine
- CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis
- Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
- The CD8+ Memory Stem T Cell (TSCM) Subset Is Associated with Improved Prognosis in Chronic HIV-1 Infection
- Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort
- Short Communication: HIV Type 1 Subtype BF Leads to Faster CD4+ T Cell Loss Compared to Subtype B
Informações sobre o DOI: 10.1371/journal.pone.0075199 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
